Why did ADR.AX stock fall 33% intraday?

The intraday fall to **A$0.002** reflected heavy selling, low liquidity and weak fundamentals. Negative EPS (**-0.04**), thin cash per share and market reaction to company updates or trading flows likely triggered the move.

What are the near-term technical levels to watch for ADR.AX stock?

Key levels: immediate support **A$0.002**, resistance near the 50-day average **A$0.005** and 200-day average **A$0.00614**. Watch volume above **3,324,466** for reliable breakouts.

What is Meyka AI's price forecast for ADR.AX stock?

Meyka AI's forecast model projects **A$0.006** for ADR.AX, implying **+200.00%** versus the current **A$0.002**. Forecasts are model-based projections and not guarantees.

Is ADR.AX stock suitable for long-term portfolios?

Given negative earnings, low liquidity and small market cap, ADR.AX is speculative for long-term investors. Any allocation should be tiny, with close monitoring of cash position, earnings and potential dilution.

AU Stocks

ADR.AX Adherium (ASX) down 33% intraday 26 Feb 2026: key risk signals

ByHuzaifa Zahoor February 26, 2026February 26, 2026

ADR.AX stock plunged 33.33% intraday on 26 Feb 2026, trading at A$0.002 on the ASX after opening at A$0.005. Volume reached 1,905,316 shares, above recent averages, as sellers hit the tiny-cap healthcare device name. This intraday drop deepens year-to-date weakness and raises immediate liquidity and valuation questions for Adherium Limited (ADR.AX) on the ASX.